Inhibition of human cytochrome P450 2A6 by 7-Hydroxycoumarin (cas 93-35-6) analogues: Analysis of the structure-activity relationship and isoform selectivity
-
Add time:07/15/2019 Source:sciencedirect.com
Compared with coumarin, 7-Hydroxycoumarin (cas 93-35-6) could serve as a better hit for developing CYP2A6 inhibitors. In this study, a series of 7-hydroxycoumarin and its structural analogues were collected to study their structure-activity relationship (SAR) and isoform selectivity for inhibiting CYP2A6. All tested coumarins except a C4 phenyl derivative (11) showed higher inhibitory activities for CYP2A6 over the other CYP isoforms, including CYP1A2, CYP2D6, CYP2E1, CYP3A4, CYP2C8, and CYP2C9. Of these coumarins, 6,7-dihydroxycoumarin (1) and 7,8-dihydroxycoumarin (9) were found to be potent inhibitors of CYP2A6 with IC50/Ki value of 0.39/0.25 and 4.61/3.02 μM, respectively, compared to methoxalen as positive control (IC50/Ki = 0.43/0.26 μM). In contrast, other coumarins showed low or decreased CYP2A6-inhibiting activities. SAR analysis showed that hydroxy groups might be important for CYP2A6 inhibition, and the rank order of sites for hydroxy substitution was C6 > C7 > C8. In addition, either hydrophobic or hydrophilic substituents introduced into C4, C6 and C8 led to a reduction in CYP2A6-inhibiting activity, and the degree of influence was dependent on the size and electrical charge of substituents. Furthermore, inhibition kinetic analysis and docking simulations demonstrated that the 8-O-glucosylated coumarin derivative (17) exhibited noncompetitive inhibition against CYP2A6, while competitive inhibition patterns were noted for the other tested coumarins. The mechanisms underlying the inhibitors binding to CYP2A6 were further investigated by molecular docking study. The findings presented herein are very helpful for developing highly selective and more potent CYP2A6 inhibitors.
We also recommend Trading Suppliers and Manufacturers of 7-Hydroxycoumarin (cas 93-35-6). Pls Click Website Link as below: cas 93-35-6 suppliers
Prev:Acid dissociation constants of some β-keto esters and their chelate stability constants of divalent transition metals and dioxouranium(II)
Next:Synthesis and evaluation of bi-functional 7-Hydroxycoumarin (cas 93-35-6) platinum(IV) complexes as antitumor agents) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- XAFS study of bioactive Cu(II) complexes of 7-Hydroxycoumarin (cas 93-35-6) derivatives in organic solvents07/24/2019
- Activation of β1-adrenoceptor triggers oxidative stress mediated myocardial membrane destabilization in isoproterenol induced myocardial infarcted rats: 7-Hydroxycoumarin (cas 93-35-6) and its counter action07/23/2019
- Calorimetric and computational study of 7-Hydroxycoumarin (cas 93-35-6)07/22/2019
- Incorporation of photoluminescent 7-Hydroxycoumarin (cas 93-35-6) units onto a polyethylene matrix by means of gamma radiation07/20/2019
- 7-Hydroxycoumarin (cas 93-35-6) modulates the oxidative metabolism, degranulation and microbial killing of human neutrophils07/21/2019
- Hepatoprotective effect of 7-Hydroxycoumarin (cas 93-35-6) against Methyl glyoxal toxicity via activation of Nrf207/19/2019
- Combination of 7-Hydroxycoumarin (cas 93-35-6) in a platinum(IV) complex derived from cisplatin enhanced cytotoxicity with multiple mechanisms of action07/18/2019
- Structural investigation of Cu(II) complexes with dibromo 7-Hydroxycoumarin (cas 93-35-6) derivatives using methodology based on XAS07/17/2019
- Synthesis and evaluation of bi-functional 7-Hydroxycoumarin (cas 93-35-6) platinum(IV) complexes as antitumor agents07/16/2019
-
Health and Chemical more >
-
Related Products


